Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Tecomet Completes Acquisition of Symmetry's OEM Business

By HospiMedica International staff writers
Posted on 28 Dec 2014
Tecomet (Wilmington, MA, USA) has completed the acquisition of the Symmetry Medical (Warsaw, IN, USA) original equipment manufacturing (OEM) solutions business.

The acquisition, for USD 450 million, creates the largest orthopedic OEM manufacturer in the world, with 18 facilities located on three continents. More...
And while OEM represented about 80% of Symmetry Medical's revenues, the deal value is more than the valuation of the entire company. What remains of Symmetry Medical will become a new, publicly traded company called Symmetry Surgical, and Symmetry Medical shareholders will receive one share in the new company for every four shares they hold.

In a press statement, Tecomet, a Genstar Capital (San Francisco, CA, USA) portfolio company, said that the strategic capabilities of the Symmetry Medical OEM Solutions, a leading supplier of contract manufacturing and product solutions for the surgical instrument, orthopedic implant, and sterilization case and tray markets, will provide a complementary fit with existing Tecomet business, which includes orthopedic implants, precision surgical instruments, trauma plates and photochemical etched products for medical device customers.

“With this acquisition, Tecomet adds to an already wide array of services and creates a footprint that would take decades to build organically,” said Bill Dow, CEO of Tecomet. “We will continue to be dedicated to providing our customers the best service at the highest level of quality at competitive prices.”

“We are excited to reach this agreement with Tecomet, which will recognize the value of the OEM Solutions business and enhance the growth potential of Symmetry Surgical,” said Thomas J. Sullivan, President and CEO of Symmetry Medical. “It also provides liquidity for our shareholders along with the upside potential of Symmetry Surgical as a well-positioned, standalone company focused on the large global market for surgical instruments.”

“This is a great opportunity to have a transforming impact on the orthopedic contract manufacturing industry. Original equipment manufacturers are moving more of their manufacturing out to contract manufacturers that can handle the volume and provide the systems support,” added Genstar Capital principal Rob Rutledge. “This merger provides a contract manufacturing platform paramount to anything else in the orthopedic industry.”

Tecomet is also a leading manufacturer of precision components to the aerospace and defense industry, producing products used in missile and satellite propulsion systems, vision systems, and infrared applications.

Related Links:

Tecomet
Symmetry Medical
Genstar Capital



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.